TP53 and cancer: Nutlin-3a, the active enantiomer of nutlin-3, has been shown to inhibit growth of p53 wild-type human tumors grown as xenografts in nude mice and to induce apoptosis and cell cycle arrest in cancer cell lines that express wild-type p53 [16], [17], [18].